International Journal of Head and Neck Surgery

Register      Login

VOLUME 6 , ISSUE 2 ( April-June, 2015 ) > List of Articles

REVIEW ARTICLE

Frequency of Skip Metastases in Oral Cancer: An Overview

Achal Gulati, Shikharani Patel

Citation Information : Gulati A, Patel S. Frequency of Skip Metastases in Oral Cancer: An Overview. Int J Head Neck Surg 2015; 6 (2):80-85.

DOI: 10.5005/jp-journals-10001-1228

Published Online: 01-09-2016

Copyright Statement:  Copyright © 2015; The Author(s).


Abstract

How to cite this article

Patel S, Sakthivel P, Singh I, Gulati A, Gupta D. Frequency of Skip Metastases in Oral Cancer: An Overview. Int J Head Neck Surg 2015;6(2):80-85.


PDF Share
  1. Selective neck dissection N0 and N1 oral cavity and oropharyngeal cancer: are skip metastases a real danger. Otolaryngol 2008;33(5):450-457.
  2. Relevence of skip metastases for squamous cell carcinoma of the oral tongue and the floor of mouth. Otolaryngol Head Neck Surg 2006;134(3):460-465.
  3. Lip and oral cavity. In: Watkinson JC, Gilbert RW, MacKenzie K, McGarry G. Textbook of Head and Neck Surgery and Oncology. 5th ed. London: Hodder Arnold; 2012. p. 553-580.
  4. Pathological patterns of cervical lymph node metastases at presentation in T1 2 oral tongue cancer in Pakistan. Oral Oncol (Suppl). 2007;2(1):123.
  5. Isolated skip nodal metastases, Otolaryngol Head Neck Surg 2012;147(2):275-277.
  6. Surgical pathology of squamous carcinoma of the oral cavity: its impact on management. Semin Surg Oncol 1989;5(5):310-317.
  7. A 3-year study of supraomohyoid neck dissection and modified radical neck dissection type I in oral cancer: with special reference to involvement of level IV node metastases. Otorhinolaryngol 2010;267(6):933-938.
  8. Relationship between Selected Socio-Demographic Factors and Cancer of Oral Cavity—A Case Control Study. Cancer Informatics 2010;9(9):163-168.
  9. Elective neck dissection versus observation in stage I squamous cell carcinomas of the tongue and floor of the mouth. Otolaryngol Head Neck Surg 2001;125(1): 23-29.
  10. Are we over treating neck in buccal and alveolo-buccal cancers: experience from a tertiary cancer care center. Indian J Surg Oncol 2012;3(4):272-275.
  11. Risk factors and location of occult lymph nodes metastases in cT1-T2N0M0 squamous cell carcinoma of the tongue and the floor of the mouth. Radiother Oncol 2011;98(1):S33.
  12. Pattern of lymphatic spread from carcinoma of the buccal mucosa and its implication for less than radical surgery. J Oral Maxillofac Surg 2011;69(2): 340-345.
  13. Pattern of cervical metastases from carcinoma of the oral tongue. World J Surg Oncol 2003;1(1):10.
  14. Correlation of histological finding with clinical and radiological assessment of cervical lymph node metastases in oral cancer. J Oral Maxillofac Surg 1995; 24(1 pt 1):30-37.
  15. Concomitant radio and fluroscence guided sentinel node biopsy in squamous cell carcinoma of oral cavity using ICG-99m Tc-nanocolloid. Eur J Nucl Med Mol Imaging 2012;39(7):1128-1136.
  16. Frequency and therapeutic implication of skip metastases in the neck from squamous carcinoma of oral tongue. Head Neck 1997;19(1):14-19.
  17. Predictive value of histopathologic parameters in early squamous cell carcinoma of oral tongue. Oral Oncol 2007;43(10):1007-1013.
  18. Maddox, Peters GE, Soong S, et al. T1 And T2 Squamous cell carcinoma of the oral tongue : Prognostic factors and the role of elective lymph node dissection. Head Neck 1999;21(2):124-130.
  19. Delays in treatment of oral cancer: a review of the current literature. Oral Surg Med Pathol Radiol 2014;117(4):424-429.
  20. Surgical pathology of squamous carcinoma of the oral cavity: Its impact on management. Sem Surgical Oncol 1989;5(5):310-317.
  21. Current Management of Advanced Resectable Oral Cavity Squamous Cell Carcinoma. Clin Exp Otorhinolaryngol 2011;4(1):1-10.
  22. Management of the node negative early carcinoma tongue. Indian J Otolaryngol. Head Neck Surg 2007;59(3):229-232.
  23. Indian J Radiol Imaging. 2012;22(3):195-208.
  24. Accuracy of intraoperative staging of the NO neck in squamous cell carcinoma. Laryngoscope 1995;105(12 pt 1):1334-1336.
  25. The node-negative neck: accuracy of clinical intraoperative lymph node assessment for metastatic disease in head and neck cancer. Laryngoscope 2002;112(4):630-633.
  26. Evaluation of selective lymph node sampling in the node-negative neck. Laryngoscope 2002;112(6):1006-1009.
  27. Metastaticneckdisease. In: Watkinson JC, Gilbert RW, MacKenzie K, McGarry G, editors. Textbook of Head and Neck Surgery and Oncology. 5th ed. London: Hodder Arnold; 2012. p. 665.
  28. The topography of cervical lymph node metastases revisited: the histological findings in 526 sides of neck dissection from 439 previously untreated patients. Int J Oral Maxillofac Surg 2007;36(3):219-225.
  29. Elective neck dissection in oral carcinoma: a critical review of the evidence. Acta Otorhino-laryngol 2007;27(3):113-117.
  30. Is the dissection of level IV necessary in patients with T1-T3 N0 tongue cancer? Laryngoscope 2001;111(6):1088-1090.
  31. histological distribution of cervical lymph node metastases from intraoral/oropharyngeal squamous cell carcinomas. British J Oral Maxillofacial Surg 1999;37(3):175-180.
  32. Prevalence and localization of nodal metastases in squamous cell carcinoma of the oral cavity: role and extension of neck dissection. Eur Arch Otorhinolaryngol 2006;263(12):1131-1135.
  33. Reduction of occult metastatic disease by extension of the supraomohyoid neck dissection to include level IV. Head Neck 2003;25(9):758-762.
  34. Anatomy of the human lymphatic system. Br J Surg 1939;27(105):194-195.
  35. Reappraisal of metastatic lymph node topography in head and neck squamous cell carcinomas. Otolaryngol Head Neck Surg 2006;135(3):445-450.
  36. Genomic Profiling of oral squamous cell carcinoma by array-based comparative Genomic Hybridization. PLoS One 2013;8(2):e56165.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.